Acumen Pharmaceuticals, Inc. (ABOS)

Acumen Pharmaceuticals Statistics

Total Valuation

ABOS has a market cap or net worth of $184.14 million. The enterprise value is $78.93 million.

Market Cap	184.14M
Enterprise Value	78.93M

Important Dates

The last earnings date was Thursday, March 26, 2026, before market open.

Earnings Date	Mar 26, 2026
Ex-Dividend Date	n/a

Share Statistics

ABOS has 72.21 million shares outstanding. The number of shares has increased by 1.58% in one year.

Current Share Class	60.57M
Shares Outstanding	72.21M
Shares Change (YoY)	+1.58%
Shares Change (QoQ)	n/a
Owned by Insiders (%)	11.37%
Owned by Institutions (%)	30.04%
Float	29.27M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	n/a
Forward PS	n/a
PB Ratio	1.66
P/TBV Ratio	1.98
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 6.02, with a Debt / Equity ratio of 0.33.

Current Ratio	6.02
Quick Ratio	5.80
Debt / Equity	0.33
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	-33.12

Financial Efficiency

Return on equity (ROE) is -85.93% and return on invested capital (ROIC) is -46.55%.

Return on Equity (ROE)	-85.93%
Return on Assets (ROA)	-42.23%
Return on Invested Capital (ROIC)	-46.55%
Return on Capital Employed (ROCE)	-114.94%
Weighted Average Cost of Capital (WACC)	6.16%
Revenue Per Employee	n/a
Profits Per Employee	-$2.19M
Employee Count	61
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +114.29% in the last 52 weeks. The beta is 0.21, so ABOS's price volatility has been lower than the market average.

Beta (5Y)	0.21
52-Week Price Change	+114.29%
50-Day Moving Average	2.67
200-Day Moving Average	1.90
Relative Strength Index (RSI)	38.13
Average Volume (20 Days)	906,855

Short Selling Information

The latest short interest is 1.03 million, so 1.43% of the outstanding shares have been sold short.

Short Interest	1.03M
Short Previous Month	960,875
Short % of Shares Out	1.43%
Short % of Float	3.53%
Short Ratio (days to cover)	3.31

Income Statement

Revenue	n/a
Gross Profit	-118.93M
Operating Income	-138.23M
Pretax Income	-133.35M
Net Income	-133.35M
EBITDA	-138.17M
EBIT	-138.23M
Earnings Per Share (EPS)	-$2.21

Balance Sheet

The company has $126.61 million in cash and $30.84 million in debt, with a net cash position of $105.22 million or $1.46 per share.

Cash & Cash Equivalents	126.61M
Total Debt	30.84M
Net Cash	105.22M
Net Cash Per Share	$1.46
Equity (Book Value)	93.17M
Book Value Per Share	1.54
Working Capital	110.20M

Cash Flow

In the last 12 months, operating cash flow was -$123.66 million and capital expenditures -$88,000, giving a free cash flow of -$123.75 million.

Operating Cash Flow	-123.66M
Capital Expenditures	-88,000
Depreciation & Amortization	60,000
Net Borrowing	n/a
Free Cash Flow	-123.75M
FCF Per Share	-$1.71

Margins

Gross Margin	n/a
Operating Margin	n/a
Pretax Margin	n/a
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

ABOS does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-1.58%
Shareholder Yield	-1.58%
Earnings Yield	-72.42%
FCF Yield	-67.20%

Analyst Forecast

The average price target for ABOS is $7.75, which is 203.92% higher than the current price. The consensus rating is "Strong Buy".

Price Target	$7.75
Price Target Difference	203.92%
Analyst Consensus	Strong Buy
Analyst Count	4
Revenue Growth Forecast (5Y)	n/a
EPS Growth Forecast (5Y)	n/a

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Altman Z-Score	n/a
Piotroski F-Score	2